BlackRock Health Sciences Trust — Director's Dealing 2016

Jul 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BlackRock Health Sciences Trust (BME)
CIK: 0001314966
Period of Report: 2016-07-15

Reporting Person: ROBARDS KAREN P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-15	Performance Rights	$	A	18.89	Acquired		Common Stock (18.89)	Direct

Footnotes

F1: The Performance Rights were accrued under the BlackRock Deferred Compensation Plan.

F2: One Performance Right is convertible into the cash value of one share of BlackRock Health Sciences Trust.

F3: The Performance Rights are to be settled 100% in cash at the deferral period chosen by the reporting person.